Use of 18 F-2-deoxy-2-fluoro-D-glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat.
Seonggweon KangYoonhoi KooTaesik YunYeon ChaeDohee LeeHakhyun KimMhan-Pyo YangByeong-Teck KangPublished in: Veterinary medicine and science (2023)
Thyroid nodules are common in older cats and are mostly benign; however, carcinomas may occur infrequently. In cats, thyroid carcinomas tend to be highly metastatic. The role of 18 F-2-deoxy-2-fluoro-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in human thyroid carcinoma has been well established. However, guidelines have not yet been established for veterinary medicine. Metastasis assessment has typically been performed using CT in veterinary medicine; however, it is poorly sensitive in detecting regional lymph nodes or distant metastases if these lesions are not abnormally contrast-enhanced, enlarged or cause overt mass effects. This case suggested that FDG PET/CT may be used for staging feline thyroid carcinoma, and the results contributed to treatment recommendations.
Keyphrases
- positron emission tomography
- computed tomography
- lymph node
- contrast enhanced
- dual energy
- diffusion weighted
- magnetic resonance imaging
- image quality
- pet ct
- pet imaging
- sentinel lymph node
- neoadjuvant chemotherapy
- high grade
- endothelial cells
- diffusion weighted imaging
- blood glucose
- clinical practice
- small cell lung cancer
- squamous cell carcinoma
- magnetic resonance
- physical activity
- induced pluripotent stem cells
- adipose tissue
- middle aged
- pluripotent stem cells
- combination therapy